phenylalanine sublingual
Selected indexed studies
- Pharmacological Treatment of Tremor in Parkinson's Disease Revisited. (J Parkinsons Dis, 2023) [PMID:36847017]
- [Inhaled levodopa: from evidence to experience]. (Rev Neurol, 2024) [PMID:38916176]
- Motor response with apomorphine sublingual film and levodopa in patients with OFF episodes. (Neurodegener Dis Manag, 2023) [PMID:36562349]
_Worker-drafted node — pending editorial review._
Connections
phenylalanine sublingual protects against
phenylalanine sublingual helps
Sources
- Pharmacological Treatment of Tremor in Parkinson's Disease Revisited. (2023) pubmed
- [Inhaled levodopa: from evidence to experience]. (2024) pubmed
- Motor response with apomorphine sublingual film and levodopa in patients with OFF episodes. (2023) pubmed
- Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study. (2020) pubmed
- A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson's disease 'OFF' episodes. (2021) pubmed
- Indirect comparison of apomorphine sublingual film and levodopa inhalation powder for Parkinson's disease 'OFF' episodes. (2022) pubmed
- New pharmacologic agents for insomnia and hypersomnia. (2020) pubmed
- Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease. (2016) pubmed
- Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson's Disease. (2023) pubmed
- Old Drugs, New Delivery Systems in Parkinson's Disease. (2019) pubmed